Methods for Staging Non-small Cell Lung Cancer

Chest - Tập 143 - Trang e211S-e250S - 2013
Gerard A. Silvestri1, Anne V. Gonzalez2, Michael A. Jantz3, Mitchell L. Margolis4, Michael K. Gould5, Lynn T. Tanoue6, Loren J. Harris7, Frank C. Detterbeck8
1Medical University of South Carolina, Charleston, SC
2Montreal Chest Institute, McGill University Health Centre, Montreal, QC, Canada
3Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL
4Pulmonary Section, Philadelphia VAMC, Philadelphia, PA
5Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA
6Section of Pulmonary and Critical Care Medicine, New Haven, CT
7Maimonides Medical Center, Brooklyn, NY
8Yale University School of Medicine, New Haven, CT

Tài liệu tham khảo

Lewis, 2013, Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, 41S, 10.1378/chest.12-2344 Detterbeck, 2007, Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition), Chest, 132, 202S, 10.1378/chest.07-1362 Silvestri, 2007, Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition), Chest, 132, 178S, 10.1378/chest.07-1360 Rivera, 2013, Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e142S, 10.1378/chest.12-2353 Farjah, 2009, Multi-modality mediastinal staging for lung cancer among medicare beneficiaries, J Thorac Oncol, 4, 355, 10.1097/JTO.0b013e318197f4d9 Little, 2005, Patterns of surgical care of lung cancer patients, Ann Thorac Surg, 80, 2051, 10.1016/j.athoracsur.2005.06.071 Tsang, 1992, The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer, Thorax, 47, 3, 10.1136/thx.47.1.3 Toloza, 2003, Invasive staging of non-small cell lung cancer: a review of the current evidence, Chest, 123, 157S, 10.1378/chest.123.1_suppl.157S Toloza, 2003, Noninvasive staging of non-small cell lung cancer: a review of the current evidence, Chest, 123, 137S, 10.1378/chest.123.1_suppl.137S Eschmann, 2002, FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy, Eur J Nucl Med Mol Imaging, 29, 804, 10.1007/s00259-002-0801-x Farrell, 2000, Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease, Radiology, 215, 886, 10.1148/radiology.215.3.r00jn29886 Grant, 1988, Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer, Thorax, 43, 883, 10.1136/thx.43.11.883 Ichinose, 1989, Preoperative examination to detect distant metastasis is not advocated for asymptomatic patients with stages 1 and 2 non-small cell lung cancer. Preoperative examination for lung cancer, Chest, 96, 1104, 10.1378/chest.96.5.1104 MacManus, 2001, High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy, Int J Radiat Oncol Biol Phys, 50, 287, 10.1016/S0360-3016(01)01477-8 Michel, 1991, Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning, Thorax, 46, 469, 10.1136/thx.46.7.469 Modini, 1982, TNM staging in lung cancer: role of computed tomography, J Thorac Cardiovasc Surg, 84, 569, 10.1016/S0022-5223(19)38985-8 Quinn, 1986, Staging of non-small cell bronchogenic carcinoma. Relationship of the clinical evaluation to organ scans, Chest, 89, 270, 10.1378/chest.89.2.270 Reed, 2003, Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer, J Thorac Cardiovasc Surg, 126, 1943, 10.1016/j.jtcvs.2003.07.030 Salvatierra, 1990, Extrathoracic staging of bronchogenic carcinoma, Chest, 97, 1052, 10.1378/chest.97.5.1052 Viney, 2004, Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer, J Clin Oncol, 22, 2357, 10.1200/JCO.2004.04.126 Weder, 1998, Detection of extrathoracic metastases by positron emission tomography in lung cancer, Ann Thorac Surg, 66, 886, 10.1016/S0003-4975(98)00675-4 Cerfolio, 2005, The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival, J Thorac Cardiovasc Surg, 130, 151, 10.1016/j.jtcvs.2004.11.007 Pozo-Rodríguez, 2005, Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer, J Clin Oncol, 23, 8348, 10.1200/JCO.2004.00.6361 Serra, 2006, Routine positron tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC), J Clin Oncol, 24, 371S, 10.1200/jco.2006.24.18_suppl.7031 Verhagen, 2004, FDG-PET in staging lung cancer: how does it change the algorithm?, Lung Cancer, 44, 175, 10.1016/j.lungcan.2003.11.007 Fischer, 2009, Preoperative staging of lung cancer with combined PET-CT, N Engl J Med, 361, 32, 10.1056/NEJMoa0900043 Herder, 2006, Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study, J Clin Oncol, 24, 1800, 10.1200/JCO.2005.02.4695 Maziak, 2009, Positron emission tomography in staging early lung cancer: a randomized trial, Ann Intern Med, 151, 221, 10.7326/0003-4819-151-4-200908180-00132 van Tinteren, 2002, Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial, Lancet, 359, 1388, 10.1016/S0140-6736(02)08352-6 Morgensztern, 2008, The effect of FDG-PET on the stage distribution of non-small cell lung cancer, J Thorac Oncol, 3, 135, 10.1097/JTO.0b013e3181622c2c Morgensztern, 2009, Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005, J Thorac Oncol, 4, 1524, 10.1097/JTO.0b013e3181ba3634 Chee, 2008, Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited, Arch Intern Med, 168, 1541, 10.1001/archinte.168.14.1541 Kozower, 2008, Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?, Ann Thorac Surg, 85, 1166, 10.1016/j.athoracsur.2008.01.018 Howington, 2013, Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e278S, 10.1378/chest.12-2359 Silvestri, 1995, The clinical evaluation for detecting metastatic lung cancer. A meta-analysis, Am J Respir Crit Care Med, 152, 225, 10.1164/ajrccm.152.1.7599828 Mohammed, 2011, Rapid disease progression with delay in treatment of non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 79, 466, 10.1016/j.ijrobp.2009.11.029 Alonso Moralejo, 2010, Use of positron emission tomography in assessing hidden extrathoracic metastasis in non small cell lung cancer [in Spanish], Arch Bronconeumol, 46, 238, 10.1016/j.arbres.2010.02.003 Chiba, 2010, Significance of PET/CT in determining actual TNM staging for patients with various lung cancers, Int Surg, 95, 197 Lee, 2007, Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer, J Thorac Cardiovasc Surg, 133, 746, 10.1016/j.jtcvs.2006.10.043 Prévost, 2009, Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients [in French], Rev Pneumol Clin, 65, 341, 10.1016/j.pneumo.2009.08.008 Rodríguez Fernández, 2007, Staging of non-small cell lung cancer. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods [in Spanish], Rev Clin Esp, 207, 541, 10.1157/13111571 Sharma, 2009, The importance of 18F-FDG PET/CT, CT and X-rays in detecting primary stage III A lung cancer and the incidence of extra thoracic metastases, Hell J Nucl Med, 12, 22 De Wever, 2007, Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT, Eur Radiol, 17, 23, 10.1007/s00330-006-0284-4 Heo, 2010, Impact of whole-body 18F-fluorodeoxyglucose positron emission tomography on therapeutic management of non-small cell lung cancer, Respirology, 15, 1174, 10.1111/j.1440-1843.2010.01790.x Margery, 2010, Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study [in French], Rev Pneumol Clin, 66, 313, 10.1016/j.pneumo.2010.07.015 Subedi, 2009, The clinical impact of integrated FDG PET-CT on management decisions in patients with lung cancer, Lung Cancer, 64, 301, 10.1016/j.lungcan.2008.09.006 Lu, 2010, 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients, Neoplasma, 57, 129, 10.4149/neo_2010_02_129 Ozcan Kara, 2011, The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions, Nucl Med Commun, 32, 106, 10.1097/MNM.0b013e32834199e7 Grassetto, 2010, Additional value of FDG-PET/CT in management of “solitary” liver metastases: preliminary results of a prospective multicenter study, Mol Imaging Biol, 12, 139, 10.1007/s11307-009-0249-5 Song, 2009, Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer, Lung Cancer, 65, 333, 10.1016/j.lungcan.2008.12.004 Akamatsu, 2010, Intestinal metastasis from non-small-cell lung cancer initially detected by 18F-fluorodeoxyglucose positron emission tomography, Jpn J Radiol, 28, 684, 10.1007/s11604-010-0470-9 Lee, 2010, Unexpected small bowel intussusception caused by lung cancer metastasis on 18F-fluorodeoxyglucose PET-CT, Ann Thorac Surg, 90, 2037, 10.1016/j.athoracsur.2010.04.103 Purandare, 2008, Isolated asymptomatic skeletal muscle metastasis in a potentially resectable non-small cell lung cancer: detection with FDG PET-CT scanning, Cancer Imaging, 8, 216, 10.1102/1470-7330.2008.0033 Lee, 2008, Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer, Ann Nucl Med, 22, 281, 10.1007/s12149-007-0104-1 De Wever, 2010, Staging of lung cancer. Do we need a diagnostic CT of the brain after an integrated PET/CT for the detection of brain metastases?, JBR-BTR, 93, 71 Koo, 2011, Factors associated with recurrence in patients with curatively resected stage I-II lung cancer, Lung Cancer, 73, 222, 10.1016/j.lungcan.2010.11.013 Nishikawa, 2010, Early detection of metachronous brain metastases by biannual brain MRI follow-up may provide patients with non-small cell lung cancer with more opportunities to have radiosurgery, Clin Neurol Neurosurg, 112, 770, 10.1016/j.clineuro.2010.06.009 Sánchez de Cos, 2009, Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors, Lung Cancer, 63, 140, 10.1016/j.lungcan.2008.04.013 Schreyögg, 2010, Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer, J Nucl Med, 51, 1668, 10.2967/jnumed.109.072090 Wauters, 2010, Impact of FDG-PET-induced treatment choices on long-term outcome in non-small cell lung cancer, Respiration, 79, 97, 10.1159/000218167 Søgaard, 2011, Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial, Eur J Nucl Med Mol Imaging, 38, 802, 10.1007/s00259-010-1703-y Borrego Dorado, 2007, Evaluation of efficacy and clinical impact of FDG-PET on patients with potentially resectable non-small cell lung cancer [in Spanish], Rev Esp Med Nucl, 26, 335, 10.1157/13112359 Nosotti, 2008, Staging non-small lung cancer with positron emission tomography: diagnostic value, impact on patient management, and cost-effectiveness, Int Surg, 93, 278 Li, 2009, Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer, Lung Cancer, 63, 383, 10.1016/j.lungcan.2008.06.004 Oven Ustaalioglu, 2010, Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience, J BUON, 15, 529 Basu, 2009, Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions, Q J Nucl Med Mol Imaging, 53, 9 Uesaka, 2008, Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer, J Nucl Med, 49, 1606, 10.2967/jnumed.108.051250 Mac Manus, 2010, Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer, Q J Nucl Med Mol Imaging, 54, 510 de Geus-Oei, 2007, Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer, J Nucl Med, 48, 1592, 10.2967/jnumed.107.043414 Nahmias, 2007, Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT, J Nucl Med, 48, 744, 10.2967/jnumed.106.038513 Nogová, 2009, Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus, J Nucl Med, 50, 1815, 10.2967/jnumed.109.065367 Lauer, 2007, [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias, Arch Intern Med, 167, 161, 10.1001/archinte.167.2.161 Lardinois, 2005, Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer, J Clin Oncol, 23, 6846, 10.1200/JCO.2005.10.116 Nakamura, 2008, Fluorodeoxyglucose positron emission tomography integrated with computed tomography to determine resectability of primary lung cancer, Gen Thorac Cardiovasc Surg, 56, 404, 10.1007/s11748-008-0272-5 Carnochan, 2009, Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients, Eur J Cardiothorac Surg, 35, 781, 10.1016/j.ejcts.2009.01.031 De Wever, 2007, Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer, Eur Respir J, 29, 995, 10.1183/09031936.00119106 Herder, 2002, Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals, Thorax, 57, 11, 10.1136/thorax.57.1.11 Hillers, 1994, Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer, Thorax, 49, 14, 10.1136/thx.49.1.14 Goerg, 1992, Adrenal masses in lung cancer: sonographic diagnosis and follow-up, Eur J Cancer, 28A, 1400, 10.1016/0959-8049(92)90529-B Oliver, 1984, Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma, Radiology, 153, 217, 10.1148/radiology.153.1.6473783 Burt, 1994, Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging, J Thorac Cardiovasc Surg, 107, 584, 10.1016/S0022-5223(94)70106-7 Heavey, 1986, The role of CT in staging radiographic T1N0M0 lung cancer, AJR Am J Roentgenol, 146, 285, 10.2214/ajr.146.2.285 Pearlberg, 1985, T1N0M0 bronchogenic carcinoma: assessment by CT, Radiology, 157, 187, 10.1148/radiology.157.1.4034964 Eggesbø, 1996, Clinical impact of adrenal expansive lesions in bronchial carcinoma, Acta Radiol, 37, 343, 10.1177/02841851960371P172 Ettinghausen, 1991, Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer, J Clin Oncol, 9, 1462, 10.1200/JCO.1991.9.8.1462 Boland, 1995, Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose, Radiology, 194, 131, 10.1148/radiology.194.1.7997539 Marom, 1999, Staging non-small cell lung cancer with whole-body PET, Radiology, 212, 803, 10.1148/radiology.212.3.r99se21803 Erasmus, 1997, Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography, AJR Am J Roentgenol, 168, 1357, 10.2214/ajr.168.5.9129444 Pieterman, 2000, Preoperative staging of non-small-cell lung cancer with positron-emission tomography, N Engl J Med, 343, 254, 10.1056/NEJM200007273430404 Stroobants, 2003, Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer, Clin Lung Cancer, 4, 242, 10.3816/CLC.2003.n.005 Gillams, 1992, The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer, Clin Radiol, 46, 18, 10.1016/S0009-9260(05)80027-3 Macari, 1998, Non-small cell lung carcinoma: usefulness of unenhanced helical CT of the adrenal glands in an unmonitored environment, Radiology, 209, 807, 10.1148/radiology.209.3.9844679 Porte, 1999, Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?, Eur J Cardiothorac Surg, 15, 597, 10.1016/S1010-7940(99)00047-0 Heinz-Peer, 1999, Characterization of adrenal masses using MR imaging with histopathologic correlation, AJR Am J Roentgenol, 173, 15, 10.2214/ajr.173.1.10397092 Gross, 1988, Distinguishing benign from malignant euadrenal masses, Ann Intern Med, 109, 613, 10.7326/0003-4819-109-8-613 Chapman, 1984, Upper abdominal computerized tomography scanning in staging non-small cell lung carcinoma, Cancer, 54, 1541, 10.1002/1097-0142(19841015)54:8<1541::AID-CNCR2820540812>3.0.CO;2-N Nielsen, 1982, Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma, AJR Am J Roentgenol, 139, 317, 10.2214/ajr.139.2.317 The American Thoracic Society and The European Respiratory Society, 1997, Pretreatment evaluation of non-small-cell lung cancer, Am J Respir Crit Care Med, 156, 320, 10.1164/ajrccm.156.1.ats156.1 Hustinx, 1998, Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases, Ann Oncol, 9, 397, 10.1023/A:1008290027419 Butler, 1979, The value of routine cranial computed tomography in neurologically intact patients with primary carcinoma of the lung, Radiology, 131, 339, 10.1148/131.2.399 Cole, 1994, Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile?, Ann Thorac Surg, 57, 838, 10.1016/0003-4975(94)90185-6 Colice, 1995, Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases, Chest, 108, 1264, 10.1378/chest.108.5.1264 Ferrigno, 1994, Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer, Chest, 106, 1025, 10.1378/chest.106.4.1025 Jacobs, 1977, ‘Silent’ brain metastasis from lung carcinoma determined by computerized tomography, Arch Neurol, 34, 690, 10.1001/archneur.1977.00500230060010 Kormas, 1992, Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma, Thorax, 47, 106, 10.1136/thx.47.2.106 Mintz, 1984, Intracranial metastases in the initial staging of bronchogenic carcinoma, Chest, 86, 850, 10.1378/chest.86.6.850 Tarver, 1984, Cerebral metastases from lung carcinoma: neurological and CT correlation. Work in progress, Radiology, 153, 689, 10.1148/radiology.153.3.6093189 Patchell, 1990, A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, 322, 494, 10.1056/NEJM199002223220802 Davis, 1991, Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enchanced MR imaging, AJR, 156, 1039 Yokoi, 1999, Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI, Chest, 115, 714, 10.1378/chest.115.3.714 Earnest, 1999, Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection—pilot study, Radiology, 211, 137, 10.1148/radiology.211.1.r99ap34137 Hochstenbag, 2003, MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?, Lung Cancer, 42, 189, 10.1016/S0169-5002(03)00291-5 Osada, 1987, The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer, Jpn J Surg, 17, 362, 10.1007/BF02470635 Turner, 1981, Preoperative radionuclide scanning in bronchogenic carcinoma, Br J Dis Chest, 75, 291, 10.1016/0007-0971(81)90008-5 Bury, 1998, Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer, Eur J Nucl Med, 25, 1244, 10.1007/s002590050291 Hsia, 2002, Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer, Neoplasma, 49, 267 Schirrmeister, 1999, Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET, J Nucl Med, 40, 1623 Carretta, 2002, Therapeutic strategy in patients with non-small cell lung cancer associated to satellite pulmonary nodules, Eur J Cardiothorac Surg, 21, 1100, 10.1016/S1010-7940(02)00108-2 Erasmus, 2000, FDG PET of pleural effusions in patients with non-small cell lung cancer, AJR Am J Roentgenol, 175, 245, 10.2214/ajr.175.1.1750245 Gupta, 2002, Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion, Chest, 122, 1918, 10.1378/chest.122.6.1918 Duysinx, 2004, Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging, Chest, 125, 489, 10.1378/chest.125.2.489 Cerfolio, 2005, Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial, Ann Thorac Surg, 80, 1207, 10.1016/j.athoracsur.2005.04.019 Bollen, 1994, Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer, Ann Thorac Surg, 58, 158, 10.1016/0003-4975(94)91091-X Ratto, 1990, Improving clinical efficacy of computed tomographic scan in the preoperative assessment of patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 99, 416, 10.1016/S0022-5223(19)36971-5 Lee, 2009, 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity, Eur J Nucl Med Mol Imaging, 36, 1794, 10.1007/s00259-009-1155-4 Yen, 2008, 18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?, Eur J Nucl Med Mol Imaging, 35, 1305, 10.1007/s00259-008-0733-1 Yang, 2008, Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer [published correction appears in Lung Cancer. 2009;63(2):305], Lung Cancer, 61, 35, 10.1016/j.lungcan.2007.11.007 Yi, 2007, Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer, AJR Am J Roentgenol, 188, 318, 10.2214/AJR.05.2081 Turkmen, 2007, The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high, Clin Nucl Med, 32, 607, 10.1097/RLU.0b013e3180a1ac87 Ebihara, 2006, Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients, Jpn J Clin Oncol, 36, 694, 10.1093/jjco/hyl092 Takamochi, 2005, Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients, Lung Cancer, 47, 235, 10.1016/j.lungcan.2004.08.004 Nomori, 2004, Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images, Lung Cancer, 45, 19, 10.1016/j.lungcan.2004.01.009 Kelly, 2004, Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer, Chest, 125, 1413, 10.1378/chest.125.4.1413 Kimura, 2003, A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers, Ann Thorac Surg, 75, 1734, 10.1016/S0003-4975(03)00035-3 Schillaci, 2003, Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT, J Nucl Med, 44, 1219 Eggeling, 2002, Invasive staging of non-small cell lung cancer—a prospective study, Eur J Cardiothorac Surg, 22, 679, 10.1016/S1010-7940(02)00479-7 Kiernan, 2002, Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography, South Med J, 95, 1168 Nosotti, 2002, Role of (99m)tc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer, Chest, 122, 1361, 10.1378/chest.122.4.1361 von Haag, 2002, Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer, J Surg Res, 103, 160, 10.1006/jsre.2002.6354 Laudanski, 2001, The preoperative study of mediastinal lymph nodes metastasis in lung cancer by endoscopic ultrasonography (EUS) and helical computed tomography (CT), Lung Cancer, 34, S123, 10.1016/S0169-5002(01)00353-1 Poncelet, 2001, PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma, Eur J Cardiothorac Surg, 20, 468, 10.1016/S1010-7940(01)00827-2 Wallace, 2001, Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung, Ann Thorac Surg, 72, 1861, 10.1016/S0003-4975(01)03205-2 Dunagan, 2001, Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer, Chest, 119, 333, 10.1378/chest.119.2.333 Kamiyoshihara, 2001, Mediastinal lymph node evaluation by computed tomographic scan in lung cancer, J Cardiovasc Surg (Torino), 42, 119 Osada, 2001, Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer, Jpn J Thorac Cardiovasc Surg, 49, 1, 10.1007/BF02913116 Takamochi, 2000, The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer, J Thorac Cardiovasc Surg, 119, 1135, 10.1067/mtc.2000.105830 Saunders, 1999, Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer, Ann Thorac Surg, 67, 790, 10.1016/S0003-4975(98)01257-0 Suzuki, 1999, Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer, J Thorac Cardiovasc Surg, 117, 593, 10.1016/S0022-5223(99)70340-5 Vansteenkiste, 1998, Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients, J Clin Oncol, 16, 2142, 10.1200/JCO.1998.16.6.2142 Vansteenkiste, 1998, FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group, Eur J Nucl Med, 25, 1495, 10.1007/s002590050327 Bury, 1997, Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer, Eur Respir J, 10, 2529, 10.1183/09031936.97.10112529 Gdeedo, 1997, Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging, Eur Respir J, 10, 1547, 10.1183/09031936.97.10071547 Buccheri, 1996, Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer, Thorax, 51, 359, 10.1136/thx.51.4.359 Bury, 1996, Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer, Eur Respir J, 9, 2560, 10.1183/09031936.96.09122560 Aaby, 1995, Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy, ORL J Otorhinolaryngol Relat Spec, 57, 279, 10.1159/000276758 Primack, 1994, Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions, Radiology, 193, 795, 10.1148/radiology.193.3.7972827 Yokoi, 1994, Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT—comparison with CT, Radiology, 192, 813, 10.1148/radiology.192.3.8058953 McLoud, 1992, Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling, Radiology, 182, 319, 10.1148/radiology.182.2.1732943 Jolly, 1991, Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer, J Thorac Cardiovasc Surg, 102, 266, 10.1016/S0022-5223(19)36559-6 Cole, 1993, Computerised tomography does not predict N2 disease in patients with lung cancer, Aust N Z J Med, 23, 688, 10.1111/j.1445-5994.1993.tb04728.x Webb, 1991, CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group, Radiology, 178, 705, 10.1148/radiology.178.3.1847239 Dwamena, 1999, Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT, Radiology, 213, 530, 10.1148/radiology.213.2.r99nv46530 Gould, 2003, Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis, Ann Intern Med, 139, 879, 10.7326/0003-4819-139-11-200311180-00013 Nolop, 1987, Glucose utilization in vivo by human pulmonary neoplasms, Cancer, 60, 2682, 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H Wahl, 1991, 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography, Cancer, 67, 1544, 10.1002/1097-0142(19910315)67:6<1544::AID-CNCR2820670614>3.0.CO;2-0 Weber, 1955, Glucose-6-phosphatase activity in normal, pre-cancerous, and neoplastic tissues, Cancer Res, 15, 105 Gupta, 2000, Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions, Chest, 117, 773, 10.1378/chest.117.3.773 Detterbeck, 2004, Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer, Chest, 125, 2300, 10.1378/chest.125.6.2300 Detterbeck, 2004, Seeking a home for a PET, part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses, Chest, 125, 2294, 10.1378/chest.125.6.2294 Gupta, 1996, Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET, J Nucl Med, 37, 943 Higashi, 1998, Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma, J Nucl Med, 39, 1016 Kim, 1998, Localized form of bronchioloalveolar carcinoma: FDG PET findings, AJR Am J Roentgenol, 170, 935, 10.2214/ajr.170.4.9530038 Bernasconi, 2006, Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC, Eur Respir J, 27, 889, 10.1183/09031936.06.00125605 Fritscher-Ravens, 2003, Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration, Chest, 123, 442, 10.1378/chest.123.2.442 Sazon, 1996, Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer, Am J Respir Crit Care Med, 153, 417, 10.1164/ajrccm.153.1.8542152 Antoch, 2003, Non-small cell lung cancer: dual-modality PET/CT in preoperative staging, Radiology, 229, 526, 10.1148/radiol.2292021598 Lardinois, 2003, Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N Engl J Med, 348, 2500, 10.1056/NEJMoa022136 Roman, 2001, Staging and managing lung tumors using F-18 FDG coincidence detection, Clin Nucl Med, 26, 383, 10.1097/00003072-200105000-00001 Billé, 2009, Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography, Eur J Cardiothorac Surg, 36, 440, 10.1016/j.ejcts.2009.04.003 Cerfolio, 2004, The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer, Ann Thorac Surg, 78, 1017, 10.1016/j.athoracsur.2004.02.067 Fischer, 2011, PET-CT in preoperative staging of lung cancer, N Engl J Med, 364, 980, 10.1056/NEJMc1012974 Lee, 2009, Integrated positron-emission tomography for nodal staging in lung cancer, Asian Cardiovasc Thorac Ann, 17, 622, 10.1177/0218492309349253 Perigaud, 2009, Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer, Eur J Cardiothorac Surg, 36, 731, 10.1016/j.ejcts.2009.05.044 Plathow, 2008, Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced nonsmall cell lung cancer—initial results, Invest Radiol, 43, 290, 10.1097/RLI.0b013e318163273a Sanli, 2009, Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 138, 1200, 10.1016/j.jtcvs.2009.03.035 Shin, 2008, FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications, Korean J Radiol, 9, 481, 10.3348/kjr.2008.9.6.481 Toba, 2010, Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer, J Med Invest, 57, 305, 10.2152/jmi.57.305 Usuda, 2011, Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers, Ann Thorac Surg, 91, 1689, 10.1016/j.athoracsur.2011.02.037 Yi, 2008, Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging, Radiology, 248, 632, 10.1148/radiol.2482071822 Herth, 2008, Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer, Chest, 133, 887, 10.1378/chest.07-2535 Herth, 2006, Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum, Eur Respir J, 28, 910, 10.1183/09031936.06.00124905 Crisci, 1997, MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA, Eur J Cardiothorac Surg, 11, 214, 10.1016/S1010-7940(96)01047-0 Kernstine, 1999, PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma, Ann Thorac Surg, 68, 1022, 10.1016/S0003-4975(99)00788-2 Heelan, 1989, Superior sulcus tumors: CT and MR imaging, Radiology, 170, 637, 10.1148/radiology.170.3.2916014 Manfredi, 1996, Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma, MAGMA, 4, 257, 10.1007/BF01772015 Padovani, 1993, Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging, Radiology, 187, 33, 10.1148/radiology.187.1.8451432 Shiotani, 2000, Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging, Radiat Med, 18, 283 Cybulsky, 1994, Mediastinoscopy as a routine outpatient procedure, Ann Thorac Surg, 58, 176, 10.1016/0003-4975(94)91095-2 Selby, 1978, Local anesthesia for mediastinoscopy: experience with 450 consecutive cases, Am Surg, 44, 679 Vallières, 1991, Ambulatory mediastinoscopy and anterior mediastinotomy, Ann Thorac Surg, 52, 1122, 10.1016/0003-4975(91)91291-3 Kiser, 2001, General aspects of surgical treatment, 133 Leschber, 2008, Does video-mediastinoscopy improve the results of conventional mediastinoscopy?, Eur J Cardiothorac Surg, 33, 289, 10.1016/j.ejcts.2007.10.021 Venissac, 2003, Video-assisted mediastinoscopy: experience from 240 consecutive cases, Ann Thorac Surg, 76, 208, 10.1016/S0003-4975(03)00164-4 Kim, 2011, Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography, J Thorac Oncol, 6, 336, 10.1097/JTO.0b013e318201212e Park, 2010, Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT, Respirology, 15, 1179, 10.1111/j.1440-1843.2010.01793.x Block, 2010, Transition from mediastinoscopy to endoscopic ultrasound for lung cancer staging, Ann Thorac Surg, 89, 885, 10.1016/j.athoracsur.2009.11.034 Anraku, 2010, Video-assisted mediastinoscopy compared with conventional mediastinoscopy: are we doing better?, Ann Thorac Surg, 89, 1577, 10.1016/j.athoracsur.2010.02.012 Annema, 2010, Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial, JAMA, 304, 2245, 10.1001/jama.2010.1705 Meyers, 2006, Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer, J Thorac Cardiovasc Surg, 131, 822, 10.1016/j.jtcvs.2005.10.045 Lemaire, 2006, Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate, Ann Thorac Surg, 82, 1185, 10.1016/j.athoracsur.2006.05.023 Fibla, 2006, The yield of mediastinoscopy with respect to lymph node size, cell type, and the location of the primary tumor, J Thorac Oncol, 1, 430, 10.1016/S1556-0864(15)31607-5 Cerfolio, 2006, Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study, Chest, 130, 1791, 10.1378/chest.130.6.1791 Choi, 2003, Mediastinoscopy in patients with clinical stage I non-small cell lung cancer, Ann Thorac Surg, 75, 364, 10.1016/S0003-4975(02)04411-9 Gürses, 2002, The value of mediastinoscopy in preoperative evaluation of mediastinal involvement in non-small-cell lung cancer patients with clinical NO disease, Thorac Cardiovasc Surg, 50, 174, 10.1055/s-2002-32416 Hammoud, 1999, The current role of mediastinoscopy in the evaluation of thoracic disease, J Thorac Cardiovasc Surg, 118, 894, 10.1016/S0022-5223(99)70059-0 Ebner, 1999, Clinical value of cervical mediastinoscopy in the staging of bronchial carcinoma, Ann Ital Chir, 70, 873 Gdeedo, 1997, Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma, Eur J Cardiothorac Surg, 12, 224, 10.1016/S1010-7940(97)00084-5 De Leyn, 1996, Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease), Eur J Cardiothorac Surg, 10, 649, 10.1016/S1010-7940(96)80380-0 Dillemans, 1994, Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. A study of 569 patients, Eur J Cardiothorac Surg, 8, 37, 10.1016/1010-7940(94)90131-7 Ríordáin, 1991, Mediastinoscopy as a predictor of resectability in patients with bronchogenic carcinoma, Ir J Med Sci, 160, 291, 10.1007/BF02948416 Pagé, 1987, Surgical treatment of bronchogenic carcinoma: the importance of staging in evaluating late survival, Can J Surg, 30, 96 Luke, 1986, Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung, J Thorac Cardiovasc Surg, 91, 53, 10.1016/S0022-5223(19)38480-6 Coughlin, 1985, Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer, Ann Thorac Surg, 40, 556, 10.1016/S0003-4975(10)60348-7 Brion, 1985, Role of computed tomography and mediastinoscopy in preoperative staging of lung carcinoma, J Comput Assist Tomogr, 9, 480, 10.1097/00004728-198505000-00011 Deneffe, 1983, Cervical mediastinoscopy and anterior mediastinotomy in patients with lung cancer and radiologically normal mediastinum, Eur J Respir Dis, 64, 613 Lardinois, 2003, Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer, Ann Thorac Surg, 75, 1102, 10.1016/S0003-4975(02)04714-8 Staples, 1988, Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy, Radiology, 167, 367, 10.1148/radiology.167.2.3357944 Van Den Bosch, 1983, Exploratory thoracotomy in bronchial carcinoma, J Thorac Cardiovasc Surg, 85, 733, 10.1016/S0022-5223(19)37510-5 Sayar, 2011, Comparison of video-assisted mediastinoscopy and video-assisted mediastinoscopic lymphadenectomy for lung cancer, Gen Thorac Cardiovasc Surg, 59, 793, 10.1007/s11748-011-0819-8 Kimura, 2007, Indications for mediastinoscopy and comparison of lymph node dissections in candidates for lung cancer surgery, Lung Cancer, 56, 349, 10.1016/j.lungcan.2007.01.018 Detterbeck, 2001, Surgical treatment of stage IIIa (N2) non-small cell lung cancer, 244 Barendregt, 1995, The value of parasternal mediastinoscopy in staging bronchial carcinoma, Eur J Cardiothorac Surg, 9, 655, 10.1016/S1010-7940(05)80113-7 Nechala, 2006, Retrospective analysis of the clinical performance of anterior mediastinotomy, Ann Thorac Surg, 82, 2004, 10.1016/j.athoracsur.2006.06.031 Freixinet Gilart, 2000, Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma, Ann Thorac Surg, 70, 1641, 10.1016/S0003-4975(00)01825-7 Ginsberg, 1987, Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe, J Thorac Cardiovasc Surg, 94, 673, 10.1016/S0022-5223(19)36179-3 Metin, 2011, J Thorac Oncol, 6, 1713, 10.1097/JTO.0b013e318225914e Obiols, 2012, Extended cervical mediastinoscopy: mature results of a clinical protocol for staging bronchogenic carcinoma of the left lung, Eur J Cardiothorac Surg, 41, 1043, 10.1093/ejcts/ezr181 Cerfolio, 2007, Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer, Ann Thorac Surg, 84, 940, 10.1016/j.athoracsur.2007.04.078 Massone, 2003, The real impact and usefulness of video-assisted thoracoscopic surgery in the diagnosis and therapy of clinical lymphadenopathies of the mediastinum, Ann Surg Oncol, 10, 1197, 10.1245/ASO.2003.03.538 Sebastián-Quetglás, 2003, Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer. A prospective study of 105 patients, Lung Cancer, 42, 297, 10.1016/j.lungcan.2003.06.001 De Giacomo, 1997, Thoracoscopic staging of IIIB non-small cell lung cancer before neoadjuvant therapy, Ann Thorac Surg, 64, 1409, 10.1016/S0003-4975(97)00764-9 Landreneau, 1993, Thoracoscopic mediastinal lymph node sampling: useful for mediastinal lymph node stations inaccessible by cervical mediastinoscopy, J Thorac Cardiovasc Surg, 106, 554, 10.1016/S0022-5223(19)34094-2 Loscertales, 1997, The use of videoassisted thoracic surgery in lung cancer: evaluation of resectability in 296 patients and 71 pulmonary exeresis with radical lymphadenectomy, Eur J Cardiothorac Surg, 12, 892, 10.1016/S1010-7940(97)00254-6 Roberts, 1999, Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer, Ann Thorac Surg, 68, 1154, 10.1016/S0003-4975(99)00983-2 Wain, 1993, Video-assisted thoracoscopy and the staging of lung cancer, Ann Thorac Surg, 56, 776, 10.1016/0003-4975(93)90978-Q Roviaro, 1996, Videothoracoscopic operative staging for lung cancer, Int Surg, 81, 252 Protopapas, 1996, Transthoracic needle biopsy of mediastinal lymph nodes for staging lung and other cancers, Radiology, 199, 489, 10.1148/radiology.199.2.8668801 Böcking, 1995, Cytologic versus histologic evaluation of needle biopsy of the lung, hilum and mediastinum. Sensitivity, specificity and typing accuracy, Acta Cytol, 39, 463 de Gregorio Ariza, 1991, Transthoracic aspiration biopsy of pulmonary and mediastinal lesions, Eur J Radiol, 12, 98, 10.1016/0720-048X(91)90106-6 Moinuddin, 1984, Mediastinal needle biopsy, AJR Am J Roentgenol, 143, 531, 10.2214/ajr.143.3.531 Westcott, 1981, Percutaneous needle aspiration of hilar and mediastinal masses, Radiology, 141, 323, 10.1148/radiology.141.2.7291553 Bilaçeroğlu, 1998, Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma, Respiration, 65, 441, 10.1159/000029312 Garpestad, 2001, CT fluoroscopic guidance for transbronchial needle aspiration: an experience in 35 patients, Chest, 119, 329, 10.1378/chest.119.2.329 Rodríguez de Castro, 1995, Transbronchial fine needle aspiration in clinical practice, Cytopathology, 6, 22, 10.1111/j.1365-2303.1995.tb00004.x Vansteenkiste, 1994, Transcarinal needle aspiration biopsy in the staging of lung cancer, Eur Respir J, 7, 265, 10.1183/09031936.94.07020265 Fernández-Villar, 2010, Validity and reliability of transbronchial needle aspiration for diagnosing mediastinal adenopathies, BMC Pulm Med, 10, 24, 10.1186/1471-2466-10-24 Harrow, 2000, The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma, Am J Respir Crit Care Med, 161, 601, 10.1164/ajrccm.161.2.9902040 Katis, 1998, Bronchoscopic needle aspiration in mediastinal staging of patients with bronchogenic carcinoma, J Bronchol, 5, 195, 10.1097/00128594-199807000-00004 Mak, 2004, Transbronchial needle aspiration and positron emission tomography in the diagnosis of lung cancer, J Bronchol, 11, 237, 10.1097/01.lab.0000139763.44207.07 Medford, 2010, A prospective study of conventional transbronchial needle aspiration: performance and cost utility, Respiration, 79, 482, 10.1159/000277931 Melloni, 2009, Transbronchial needle aspiration in lung cancer patients suitable for operation with positive mediastinal positron emission tomography, Ann Thorac Surg, 87, 373, 10.1016/j.athoracsur.2008.10.081 Patelli, 2002, Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer, Ann Thorac Surg, 73, 407, 10.1016/S0003-4975(01)03447-6 Rakha, 2010, Cytological assessment of conventional transbronchial fine needle aspiration of lymph nodes, Cytopathology, 21, 27, 10.1111/j.1365-2303.2008.00590.x Ratto, 1988, The prognostic significance of preoperative assessment of mediastinal lymph nodes in patients with lung cancer, Chest, 93, 807, 10.1378/chest.93.4.807 Rodríguez de Castro, 1997, Relevance of training in transbronchial fine-needle aspiration technique, Chest, 111, 103, 10.1378/chest.111.1.103 Rong, 1998, CT scan directed transbronchial needle aspiration biopsy for mediastinal nodes, Chest, 114, 36, 10.1378/chest.114.1.36 Schenk, 1993, Comparison of the Wang 19-gauge and 22-gauge needles in the mediastinal staging of lung cancer, Am Rev Respir Dis, 147, 1251, 10.1164/ajrccm/147.5.1251 Schenk, 1986, Transbronchial needle aspiration staging of bronchogenic carcinoma, Am Rev Respir Dis, 134, 146 Schenk, 1989, Utility of the Wang 18-gauge transbronchial histology needle in the staging of bronchogenic carcinoma, Chest, 96, 272, 10.1378/chest.96.2.272 Selçuk, 2003, The diagnostic yield of transbronchial needle aspiration in superior vena cava syndrome, Lung Cancer, 42, 183, 10.1016/S0169-5002(03)00293-9 Shah, 2006, The role of transbronchial fine needle aspiration in an integrated care pathway for the assessment of patients with suspected lung cancer, J Thorac Oncol, 1, 324, 10.1016/S1556-0864(15)31589-6 Shannon, 1996, Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy, Am J Respir Crit Care Med, 153, 1424, 10.1164/ajrccm.153.4.8616576 Stratakos, 2008, Exclusive diagnostic contribution of the histology specimens obtained by 19-gauge transbronchial aspiration needle in suspected malignant intrathoracic lymphadenopathy, Chest, 133, 131, 10.1378/chest.07-1920 Utz, 1993, The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma, Chest, 104, 1012, 10.1378/chest.104.4.1012 Wallace, 2008, Minimally invasive endoscopic staging of suspected lung cancer, JAMA, 299, 540, 10.1001/jama.299.5.540 Wang, 1983, Flexible transbronchial needle aspiration for staging of bronchogenic carcinoma, Chest, 84, 571, 10.1378/chest.84.5.571 Wilsher, 1996, Transtracheal aspiration using rigid bronchoscopy and a rigid needle for investigating mediastinal masses, Thorax, 51, 197, 10.1136/thx.51.2.197 Shure, 1984, The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma, Chest, 86, 693, 10.1378/chest.86.5.693 Holty, 2005, Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis, Thorax, 60, 949, 10.1136/thx.2005.041525 Fritscher-Ravens, 2000, Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer, Chest, 117, 339, 10.1378/chest.117.2.339 Gress, 1997, Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study, Ann Intern Med, 127, 604, 10.7326/0003-4819-127-8_Part_1-199710150-00004 Kramer, 2004, Endoscopic ultrasound-guided fine-needle aspiration in patients with mediastinal abnormalities and previous extrathoracic malignancy, Eur J Cancer, 40, 559, 10.1016/j.ejca.2003.11.010 Silvestri, 1996, Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer, Ann Thorac Surg, 61, 1441, 10.1016/0003-4975(95)00052-6 Wiersema, 2001, Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy, Radiology, 219, 252, 10.1148/radiology.219.1.r01ap44252 Annema, 2010, Implementation of endoscopic ultrasound for lung cancer staging, Gastrointest Endosc, 71, 64, 10.1016/j.gie.2009.07.027 Herth, 2010, Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer, Chest, 138, 790, 10.1378/chest.09-2149 Szlubowski, 2010, A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging—a prospective trial, Eur J Cardiothorac Surg, 37, 1175, 10.1016/j.ejcts.2009.11.015 Talebian, 2010, EUS-FNA in the preoperative staging of non-small cell lung cancer, Lung Cancer, 69, 60, 10.1016/j.lungcan.2009.08.016 Nadarajan, 2010, Endoscopic ultrasound with fine needle aspiration and biopsy in lung cancer and isolated mediastinal lymphadenopathy, Ir Med J, 103, 75 Kalade, 2008, Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer, Intern Med J, 38, 837, 10.1111/j.1445-5994.2008.01670.x Tournoy, 2008, The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?, J Thorac Oncol, 3, 245, 10.1097/JTO.0b013e3181653cbb Sawhney, 2007, Impact of preoperative endoscopic ultrasound on non-small cell lung cancer staging, Chest, 132, 916, 10.1378/chest.06-2571 Fernández-Esparrach, 2006, Transesophageal ultrasound-guided fine needle aspiration improves mediastinal staging in patients with non-small cell lung cancer and normal mediastinum on computed tomography, Lung Cancer, 54, 35, 10.1016/j.lungcan.2006.06.015 Eloubeidi, 2005, Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans, Ann Thorac Surg, 79, 263, 10.1016/j.athoracsur.2004.06.089 Annema, 2005, Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging, J Clin Oncol, 23, 8357, 10.1200/JCO.2005.01.1965 Annema, 2005, Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer, JAMA, 294, 931, 10.1001/jama.294.8.931 Eloubeidi, 2005, Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy, Ann Thorac Surg, 80, 1231, 10.1016/j.athoracsur.2005.04.001 Larsen, 2005, Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomised clinical trial, Lung Cancer, 49, 377, 10.1016/j.lungcan.2005.04.005 Caddy, 2005, The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC, Eur Respir J, 25, 410, 10.1183/09031936.05.00092104 LeBlanc, 2005, Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography, Am J Respir Crit Care Med, 171, 177, 10.1164/rccm.200405-581OC Wallace, 2004, Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography, Ann Thorac Surg, 77, 1763, 10.1016/j.athoracsur.2003.10.009 Annema, 2004, Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA, Lung Cancer, 44, 53, 10.1016/j.lungcan.2003.10.013 Larsen, 2002, Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management, Thorax, 57, 98, 10.1136/thorax.57.2.98 Wallace, 2004, Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography, Ann Thorac Surg, 77, 1763, 10.1016/j.athoracsur.2003.10.009 Varadarajulu, 2004, Accuracy of EUS in staging of T4 lung cancer [published correction appears in Gastrointest Endosc. 2004;59(6):752], Gastrointest Endosc, 59, 345, 10.1016/S0016-5107(03)02541-0 Aabakken, 1999, Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinotomy in patients with lung cancer and suspected mediastinal adenopathy, Endoscopy, 31, 707, 10.1055/s-1999-74 Lee, 2012, Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 143, 585, 10.1016/j.jtcvs.2011.11.022 Yasufuku, 2011, A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer, J Thorac Cardiovasc Surg, 142, 1393, 10.1016/j.jtcvs.2011.08.037 Memoli, 2011, Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer, Chest, 140, 1550, 10.1378/chest.11-0252 Cetinkaya, 2011, Efficacy of convex probe endobronchial ultrasound (CP-EBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small cell lung cancer cases with mediastinal lymphadenopathy, Ann Thorac Cardiovasc Surg, 17, 236, 10.5761/atcs.oa.10.01659 Ye, 2011, The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis, BMC Cancer, 11, 100, 10.1186/1471-2407-11-100 Steinfort, 2011, Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital, Intern Med J, 41, 815, 10.1111/j.1445-5994.2009.02142.x Hwangbo, 2010, Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer, Chest, 138, 795, 10.1378/chest.09-2100 Cerfolio, 2010, The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer, Ann Thorac Surg, 90, 427, 10.1016/j.athoracsur.2010.04.062 Sun, 2010, The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathy, Diagn Cytopathol, 38, 337 Nakajima, 2010, Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment, J Thorac Oncol, 5, 606, 10.1097/JTO.0b013e3181d35627 Gilbert, 2009, Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy, Ann Thorac Surg, 88, 896, 10.1016/j.athoracsur.2009.05.021 Ømark Petersen, 2009, The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer, Eur J Cardiothorac Surg, 36, 465, 10.1016/j.ejcts.2009.03.052 Fielding, 2009, Endobronchial ultrasound convex-probe transbronchial needle aspiration as the first diagnostic test in patients with pulmonary masses and associated hilar or mediastinal nodes, Intern Med J, 39, 435, 10.1111/j.1445-5994.2008.01731.x Hwangbo, 2009, Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer, Chest, 135, 1280, 10.1378/chest.08-2019 Szlubowski, 2009, Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging, Eur J Cardiothorac Surg, 35, 332, 10.1016/j.ejcts.2008.09.022 Rintoul, 2009, EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes-an international multi-centre experience, J Thorac Oncol, 4, 44, 10.1097/JTO.0b013e3181914357 Bauwens, 2008, Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients, Lung Cancer, 61, 356, 10.1016/j.lungcan.2008.01.005 Lee, 2008, Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?, Chest, 134, 368, 10.1378/chest.07-2105 Herth, 2006, Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions, Eur Respir J, 28, 1264, 10.1183/09031936.00013806 Yasufuku, 2006, Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer, Chest, 130, 710, 10.1378/chest.130.3.710 Yasufuku, 2005, Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer, Lung Cancer, 50, 347, 10.1016/j.lungcan.2005.07.013 Yasufuku, 2004, Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes, Chest, 126, 122, 10.1378/chest.126.1.122 Herth, 2006, Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes, Thorax, 61, 795, 10.1136/thx.2005.047829 Ohnishi, 2011, Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal nodal staging of lung cancer, Endoscopy, 43, 1082, 10.1055/s-0030-1256766 Vilmann, 2005, Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions, Endoscopy, 37, 833, 10.1055/s-2005-870276 Detterbeck, 2010, Classification of the thoroughness of mediastinal staging of lung cancer, Chest, 137, 436, 10.1378/chest.09-1378 Dietlein, 2000, Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results, Eur J Nucl Med, 27, 1598, 10.1007/s002590000376 Port, 2005, Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less, J Thorac Cardiovasc Surg, 130, 1611, 10.1016/j.jtcvs.2005.07.014 De Waele, 2006, Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy, Eur J Cardiothorac Surg, 29, 240, 10.1016/j.ejcts.2005.10.045 Meersschaut, 1992, Repeat mediastinoscopy in the assessment of new and recurrent lung neoplasm, Ann Thorac Surg, 53, 120, 10.1016/0003-4975(92)90769-Z Van Schil, 2002, Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer, Lung Cancer, 37, 281, 10.1016/S0169-5002(02)00101-0 Jett, 2013, Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e400S, 10.1378/chest.12-2363 Yamamoto, 2008, Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer, Eur J Nucl Med Mol Imaging, 35, 236, 10.1007/s00259-007-0613-0 Melek, 2008, Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer, Eur J Cardiothorac Surg, 33, 294, 10.1016/j.ejcts.2007.11.019 Halpern, 2005, Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion, Chest, 128, 2289, 10.1016/S0012-3692(15)52634-2 Demura, 2003, 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax, J Nucl Med, 44, 540 Gonzalez-Stawinski, 2003, A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer, J Thorac Cardiovasc Surg, 126, 1900, 10.1016/S0022-5223(03)01036-5 Konishi, 2003, Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings, Respiration, 70, 500, 10.1159/000074207 Zimny, 2003, Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera, Eur Radiol, 13, 740, 10.1007/s00330-002-1582-0 Kernstine, 2002, Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?, Ann Thorac Surg, 73, 394, 10.1016/S0003-4975(01)03432-4 Vesselle, 2002, The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer, J Thorac Cardiovasc Surg, 124, 511, 10.1067/mtc.2002.123130 Changlai, 2001, Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer, Oncol Rep, 8, 337 Tatsumi, 2000, Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET, J Comput Assist Tomogr, 24, 574, 10.1097/00004728-200007000-00011 Liewald, 2000, How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?, Thorac Cardiovasc Surg, 48, 93, 10.1055/s-2000-9870 Roberts, 2000, Factors associated with false-positive staging of lung cancer by positron emission tomography, Ann Thorac Surg, 70, 1154, 10.1016/S0003-4975(00)01769-0 Magnani, 1999, FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients, J Cardiovasc Surg (Torino), 40, 741 Guhlmann, 1997, Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET), Thorax, 52, 438, 10.1136/thx.52.5.438 Steinert, 1997, Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling, Radiology, 202, 441, 10.1148/radiology.202.2.9015071 Scott, 1996, Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography, J Thorac Cardiovasc Surg, 111, 642, 10.1016/S0022-5223(96)70317-3 Chin, 1995, Mediastinal staging of non-small-cell lung cancer with positron emission tomography, Am J Respir Crit Care Med, 152, 2090, 10.1164/ajrccm.152.6.8520780 Wahl, 1994, Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation, Radiology, 191, 371, 10.1148/radiology.191.2.8153308 Patterson, 1987, Significance of metastatic disease in subaortic lymph nodes, Ann Thorac Surg, 43, 155, 10.1016/S0003-4975(10)60386-4 Harewood, 2002, Cost-minimization analysis of alternative diagnostic approaches in a modeled patient with non-small cell lung cancer and subcarinal lymphadenopathy, Mayo Clin Proc, 77, 155, 10.1016/S0025-6196(11)62330-6 Ramnath, 2013, Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 143, e314S, 10.1378/chest.12-2360